Immunological Conditions Associated With Covid-19 in Patients with Hepatitis

Abstract

COVID -19 (coronavirus Disease 2019 - the disease caused by the new coronavirus 2019) continues to pose a threat to public health around the world. Epidemiological evidence suggests that patients with metabolic disorders and chronic diseases are most susceptible to SARS - CoV -2 (severe acute respiratory syndrome coronavirus 2). Among possible factors of organ damage, systemic hyperimmune inflammation due to a “cytokine storm”, cytopathic effects, hypoxia, drug toxicity, etc. are considered.